Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE7B | Q9NP56 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18325751 | 0.80 | PDE7B (0.41) | PDE7BGAAMTNR1AMTNR1BMEN1 | |
| SCHEMBL102012 | 0.77 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL14258095 | 0.77 | — | — | |
| SCHEMBL6794232 | 0.71 | FBP1 (0.35) | PDE7BGAA | |
| SCHEMBL13565572 | 0.69 | GAA (0.55) | GAAMEN1KMT2A | |
| SCHEMBL6793439 | 0.68 | ALDH1A1 (0.39) | PDE7BGAAALDH1A1HTT | |
| SCHEMBL24821765 | 0.68 | MTNR1A (0.38) | PDE7BGAAMTNR1AMTNR1B | |
| SCHEMBL30612624 | 0.67 | AKR1B1 (0.43) | PDE7BMEN1KMT2AALDH1A1AKR1B1 | |
| SCHEMBL30358393 | 0.66 | AKR1B1 (0.40) | PDE7BMEN1KMT2AAKR1B1 | |
| SCHEMBL2267342 | 0.66 | ELANE (0.39) | PDE7BGAAMTNR1AMTNR1BMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040029734-A1 | Fused-benzene derivatives useful as herbicides | ISHIHARA SANGYO KAISHA, LTD. | 2004-02-12 | — | — | US | disclosed |
| US-6573218-B1 | Defoliants containing such as uracil and 1,4-benzoxazole or benzthiazole moieties | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2003-06-03 | — | — | US | disclosed |
| EP-1111993-A4 | FUSED-BENZENE DERIVATIVES USEFUL AS HERBICIDES | ISHIHARA SANGYO KAISHA (JP) | 2002-12-04 | — | — | EP | disclosed |
| EP-1111993-A1 | FUSED-BENZENE DERIVATIVES USEFUL AS HERBICIDES | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2001-07-04 | — | — | EP | disclosed |
| WO-2000013508-A1 | FUSED-BENZENE DERIVATIVES USEFUL AS HERBICIDES | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2000-03-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029734-A1 | Fused-benzene derivatives useful as herbicides | DDT, NQO2, DHRS9 | PDE7B 4125/4885GAA 3233/4885MTNR1A 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.